跳转至内容
Merck
CN

Foxp3

Nature communications (2017-10-01)
Devy Deliyanti, Dean M Talia, Tong Zhu, Mhairi J Maxwell, Alex Agrotis, Jack R Jerome, Emily M Hargreaves, Steven Gerondakis, Margaret L Hibbs, Fabienne Mackay, Jennifer L Wilkinson-Berka
摘要

Neovascular retinopathies are major causes of vision loss; yet treatments to prevent the condition are inadequate. The role of regulatory T cells in neovascular retinopathy is unknown. Here we show that in retinopathy regulatory T cells are transiently increased in lymphoid organs and the retina, but decline when neovascularization is established. The decline is prevented following regulatory T cells expansion with an IL-2/anti-IL-2 mAb complex or the adoptive transfer of regulatory T cells. Further, both approaches reduce vasculopathy (vaso-obliteration, neovascularization, vascular leakage) and alter the activation of Tmem119